{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:11:43Z","timestamp":1791357103787,"version":"4.3.1"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/jcp.0b013e3181f15849","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T08:13:40Z","timestamp":1283415220000},"page":"579-590","source":"Crossref","is-referenced-by-count":99,"title":["Treatment Options for Bipolar Depression"],"prefix":"10.1097","volume":"30","author":[{"given":"Eduard","family":"Vieta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Locklear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Ekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Miltenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Lou","family":"Chatterton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"\u00c5str\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Paulsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 3","key":"R1-14-20210128","first-page":"S85","article-title":"Bipolar disorder-costs and comorbidity.","volume":"11","author":"Hirschfeld","year":"2005","journal-title":"Am J Manag Care"},{"issue":"suppl 2","key":"R3-14-20210128","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0924-977X(03)00076-2","article-title":"Issues in the treatment of bipolar disorder.","volume":"13","author":"Kasper","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.euroneuro.2007.03.006","article-title":"Current issues in bipolar disorder: a critical review.","volume":"17","author":"Oswald","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder.","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.","volume":"60","author":"Judd","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1399-5618.2007.00553.x","article-title":"Differences in incidence of suicide attempts during phases of bipolar I and II disorders.","volume":"10","author":"Valtonen","year":"2008","journal-title":"Bipolar Disord"},{"issue":"suppl 4","key":"R8-14-20210128","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision).","volume":"159","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269881103017002003","article-title":"Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.","volume":"17","author":"Goodwin","year":"2003","journal-title":"J Psychopharmacol"},{"key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1399-5618.2006.00432.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.","volume":"8","author":"Yatham","year":"2006","journal-title":"Bipolar Disord"},{"key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord"},{"key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":"The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.","volume":"66","author":"Suppes","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-0447.2008.01233.x","article-title":"Antidepressants in bipolar depression.","volume":"118","author":"Vieta","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"R17-14-20210128","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).","volume":"26","author":"Thase","year":"2006","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4088\/JCP.08m04942gre","article-title":"A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).","volume":"71","author":"McElroy","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"R20-14-20210128","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4088\/JCP.08m04995gre","article-title":"A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).","volume":"71","author":"Young","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R21-14-20210128","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jad.2009.10.007","article-title":"Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression.","volume":"121","author":"Suppes","year":"2010","journal-title":"J Affect Disord"},{"key":"R22-14-20210128","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/sj.npp.1301646","article-title":"N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.","volume":"33","author":"Jensen","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"suppl 5","key":"R24-14-20210128","first-page":"40","article-title":"Atypical antipsychotics in bipolar depression: potential mechanisms of action.","volume":"66","author":"Yatham","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R25-14-20210128","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pnpbp.2006.06.014","article-title":"Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications.","volume":"31","author":"Brugue","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R26-14-20210128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R27-14-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1399-5618.2007.00500.x","article-title":"Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.","volume":"10","author":"Calabrese","year":"2008","journal-title":"Bipolar Disord"},{"key":"R28-14-20210128","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4088\/JCP.08m04152","article-title":"Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.","volume":"70","author":"van der Loos","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R29-14-20210128","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","article-title":"Effectiveness of adjunctive antidepressant treatment for bipolar depression.","volume":"356","author":"Sachs","year":"2007","journal-title":"N Engl J Med"},{"key":"R30-14-20210128","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1176\/appi.ajp.161.9.1537","article-title":"Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.","volume":"161","author":"Gijsman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R31-14-20210128","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.4088\/JCP.v66n1106","article-title":"Typical and atypical antipsychotics in bipolar depression.","volume":"66","author":"Gao","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R32-14-20210128","first-page":"121","article-title":"Effectiveness and safety of adjunctive antidepressants in the treatment of bipolar depression: a review.","volume":"45","author":"Harel","year":"2008","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"R33-14-20210128","first-page":"1","article-title":"Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.","volume":"29","author":"Cruz","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"R34-14-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R35-14-20210128","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change.","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"R36-14-20210128","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4088\/JCP.v67n0703","article-title":"A 7-week, randomized, double-blind trial of olanzapine\/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.","volume":"67","author":"Brown","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R37-14-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","article-title":"Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.","volume":"28","author":"Thase","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R38-14-20210128","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R40-14-20210128","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1176\/appi.ajp.2007.06060981","article-title":"A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.","volume":"164","author":"Frye","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R41-14-20210128","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1192\/bjp.bp.105.013045","article-title":"Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.","volume":"189","author":"Post","year":"2006","journal-title":"Br J Psychiatry"},{"key":"R42-14-20210128","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4088\/JCP.v63n0607","article-title":"A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.","volume":"63","author":"Vieta","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R44-14-20210128","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R45-14-20210128","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R46-14-20210128","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/YIC.0b013e3280c28410","article-title":"Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression.","volume":"22","author":"Agosti","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"R47-14-20210128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00023210-200418010-00007","article-title":"Spotlight on lamotrigine in bipolar disorder.","volume":"18","author":"Goldsmith","year":"2004","journal-title":"CNS Drugs"},{"key":"R48-14-20210128","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/bjp.188.1.46","article-title":"Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study.","volume":"188","author":"Frangou","year":"2006","journal-title":"Br J Psychiatry"},{"key":"R49-14-20210128","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1176\/appi.ajp.158.6.906","article-title":"Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.","volume":"158","author":"Nemeroff","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R50-14-20210128","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1034\/j.1600-0447.2001.00240.x","article-title":"Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial.","volume":"104","author":"Silverstone","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"R51-14-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1517\/14656566.8.1.13","article-title":"Bipolar depression: a review of randomised clinical trials.","volume":"8","author":"Goodnick","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"R52-14-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.31887\/DCNS.2008.10.2\/dekemp","article-title":"Bipolar depression: trial-based insights to guide patient care.","volume":"10","author":"Kemp","year":"2008","journal-title":"Dialogues Clin Neurosci"},{"key":"R53-14-20210128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00004850-200405000-00001","article-title":"A review of acute treatments for bipolar depression.","volume":"19","author":"Silverstone","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"R54-14-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.161.2.217","article-title":"Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials.","volume":"161","author":"Geddes","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R55-14-20210128","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.4088\/JCP.v67n1112","article-title":"Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.","volume":"67","author":"Perlis","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R56-14-20210128","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1399-5618.2008.00611.x","article-title":"Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change.","volume":"10","author":"Martinez-Aran","year":"2008","journal-title":"Bipolar Disord"},{"key":"R57-14-20210128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-5618.2009.00726.x","article-title":"The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.","volume":"11","author":"Tohen","year":"2009","journal-title":"Bipolar Disord"},{"key":"R58-14-20210128","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1399-5618.2007.00479.x","article-title":"Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.","volume":"9","author":"Vieta","year":"2007","journal-title":"Bipolar Disord"},{"key":"R59-14-20210128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/met.2004.2.290","article-title":"The metabolic syndrome during atypical antipsychotic drug treatment: mechanisms and management.","volume":"2","author":"Baptista","year":"2004","journal-title":"Metab Syndr Relat Disord"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-201010000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T02:16:13Z","timestamp":1618020973000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201010000-00014"}},"subtitle":["A Systematic Review of Randomized, Controlled Trials"],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181f15849","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}